Prize Papers 4: Macular Disease Misc.
Chairperson(s): TBC
Speakers and presentations:
Chairperson
16:45 Welcome and introduction
K. Spooner AUSTRALIA
16:46 Discontinuing and resuming anti-VEGF therapy in nAMD
B. Fenner SINGAPORE
16:50 How common are polypoidal choroidal vasculopathy and its associated features in the general population? — A population-based study employing validated OCT-diagnostic criteria
All Faculty
16:54 Discussion
U. Chakravarthy UK
17:00 Assessment of central subfield thickness fluctuations and impact on vision in the Archway phase 3 trial of the port delivery system with Ranibizumab
R. Maturi USA
17:04 REGATTA: A phase 2a, multiple dose study of IVT GEM103 (recombinant human Complement Factor H [CFH]) in genetically selected subjects with geographic atrophy (GA) secondary to dry AMD – Clinical study outline and available baseline characteristics
All Faculty
17:08 Discussion
E. Van Dijk NETHERLANDS
17:14 Central serous chorioretinopathy in active endogenous Cushing’s syndrome
A. Canalejo Oliva SPAIN
17:18 Choroidal neovascularization in old patients with pathologic myopia: Age-related macular degeneration (AMD) or myopic neovascularization
All Faculty
17:22 Discussion
15:30 End of Session
